U.S. regulators approved Biogen Inc's (BIIB.O) aducanumab as the first treatment to attack a likely cause of Alzheimer's disease despite controversy over whether the clinical evidence pro...
Global deaths from COVID-19 have reached 1 million, but experts are still struggling to figure out a crucial metric in the pandemic: the fatality rate - the percentage of people infected ...
When he was diagnosed with COVID-19, Andre Bergmann knew exactly where he wanted to be treated: the Bethanien hospital lung clinic in Moers, near his home in northwestern Germany.
Tighter blood pressure guidelines from U.S. heart organisations mean millions more people need to make lifestyle changes, or start taking medication, in order to avoid cardiovascular prob...
